GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Notable Labs Ltd (NAS:NTBL) » Definitions » Change In Payables And Accrued Expense

Notable Labs (Notable Labs) Change In Payables And Accrued Expense : $0.04 Mil (TTM As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Notable Labs Change In Payables And Accrued Expense?

Notable Labs's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2023 was $0.04 Mil. It means Notable Labs's Accounts Payable & Accrued Expense increased by $0.04 Mil from Dec. 2022 to Dec. 2023 .

Notable Labs's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was $0.04 Mil. It means Notable Labs's Accounts Payable & Accrued Expense increased by $0.04 Mil from Dec. 2022 to Dec. 2023 .

Notable Labs Change In Payables And Accrued Expense Historical Data

The historical data trend for Notable Labs's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Notable Labs Change In Payables And Accrued Expense Chart

Notable Labs Annual Data
Trend Dec21 Dec22 Dec23
Change In Payables And Accrued Expense
0.99 -0.08 0.04

Notable Labs Semi-Annual Data
Dec21 Dec22 Dec23
Change In Payables And Accrued Expense 0.99 -0.08 0.04

Notable Labs Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2023 was $0.04 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Notable Labs Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Notable Labs's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Notable Labs (Notable Labs) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Notable Labs Ltd (NAS:NTBL) » Definitions » Change In Payables And Accrued Expense
Comparable Companies
NLSP ACST AGE CRBP NBIO CLRB AIM PLUR BIXT SNSE OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
320 Hatch Drive, Foster City, CA, USA, 94404
Website
https://notablelabs.com
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic.